Wonwoo Jeong, PhD
Research Associate,
Wake Forest Institute for Regenerative medicine, NC
Biomedical engineer, specializing in 3D bioprinting, tissue engineering, and translational regenerative medicine.
Professional Service
Young Investigator Committee (YIC) and the CTRMS Enabling Technologies Working Group, Cell Transplant and Regenerative Medicine Society (CTRMS)
Research has focused on
-Developing clinically relevant bio-inks for personalized tissue/organ manufacturing
-High throughput drug screening of patients-derived cancer organoids with tumor microenvironment
-Maturation of iPSC-derived organoids/ composite tissue
-AI-based diagnosis for tissue/organ equivalents
Research Interests
My research deeply focused translational regenerative medicine, with a strong emphasis on interdisciplinary application in 3D bioprinting.
Through joint projects with surgeons, anesthesiologists, and orthopedists, I have developed clinically relevant bio-inks, engineered artificial organ systems, and established patient-derived disease models. These collaborations have enabled the translation of bioprinting technologies into preclinical and clinical applications, fostering innovations that directly address unmet medical needs
Peer-reviewed Publications
Jeong et al., High throughput screening of patient-derived cancer organoids by improving physiological relevance with basement membrane matrix for clinical application. Acta Biomaterialia, (2025)
Jeong et al., A bio-printed breast cancer-adipose intact tissue model mimicking distance-dependent paracrine interaction to evaluate chemo- and adipokines-targeted therapies. Advanced Healthcare Materials (2025)
Lee and Jeong et al., 3D Bioprinting for Engineered Tissue Constructs and Patient‐Specific Models: Current Progress and Prospects in Clinical Applications.
Advanced Materials (2024)